← Back to Company DatabaseVisit Website
Proscia
Digital pathology platform with AI for cancer diagnostics.
Series BPhiladelphia, PAFounded 2014
About
Proscia provides a cloud-based digital pathology platform that enables laboratories to manage, analyze, and share pathology images with integrated AI applications. The platform helps pathologists work more efficiently and accurately in diagnosing cancer. Proscia's open architecture allows integration with third-party AI algorithms for various cancer detection tasks.
Total Funding
$50MKey Product
Concentriq Dx digital pathology platformGeography
North AmericaKey Investors
Highline CapitalHitachi VenturesSands Capital
Focus Areas
DiagnosticsAI / Machine Learning
Technology
AI / Machine LearningImaging / RadiologyDigital Health / Software
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026